119 related articles for article (PubMed ID: 29190917)
1. Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma.
Kim YR; Kim SJ; Cheong JW; Chung H; Jang JE; Kim Y; Yang WI; Min YH; Kim JS
Oncotarget; 2017 Nov; 8(54):92312-92323. PubMed ID: 29190917
[TBL] [Abstract][Full Text] [Related]
2. Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases.
Kato S; Takahashi E; Asano N; Tanaka T; Megahed N; Kinoshita T; Nakamura S
Histopathology; 2012 Aug; 61(2):186-99. PubMed ID: 22690710
[TBL] [Abstract][Full Text] [Related]
3. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ
Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of Plasma Epstein-Barr Virus DNA in Peripheral T-Cell Lymphomas.
Zhao D; Hu S; Zhou D; Zhang Y; Wang W; Zhang W
Acta Haematol; 2022; 145(2):132-143. PubMed ID: 34753127
[TBL] [Abstract][Full Text] [Related]
5. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.
Huang Y; Rao H; Yan S; Wang F; Wu Q; Feng Y; Zhang Y
Ann Hematol; 2017 Aug; 96(8):1331-1342. PubMed ID: 28550598
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome.
Zaja F; Russo D; Silvestri F; Fanin R; Damiani D; Infanti L; Salmaso F; Mariuzzi L; Di Loreto C; Baccarani M
Haematologica; 1997; 82(2):171-7. PubMed ID: 9175321
[TBL] [Abstract][Full Text] [Related]
7. Impact of Epstein-Barr Virus on Peripheral T-Cell Lymphoma Not Otherwise Specified and Angioimmunoblastic T-Cell Lymphoma.
Kim TY; Min GJ; Jeon YW; Park SS; Park S; Shin SH; Yahng SA; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Cho SG
Front Oncol; 2021; 11():797028. PubMed ID: 35087758
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T-cell proliferative diseases.
Suwiwat S; Pradutkanchana J; Ishida T; Mitarnun W
J Clin Virol; 2007 Dec; 40(4):277-83. PubMed ID: 17996493
[TBL] [Abstract][Full Text] [Related]
9. Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas.
Niitsu N; Okamoto M; Nakamine H; Aoki S; Motomura S; Hirano M
Hematol Oncol; 2008 Sep; 26(3):152-8. PubMed ID: 18395866
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study.
Ha SY; Sung J; Ju H; Karube K; Kim SJ; Kim WS; Seto M; Ko YH
Pathol Res Pract; 2013 Jul; 209(7):448-54. PubMed ID: 23735590
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study.
Elsayed AA; Asano N; Ohshima K; Izutsu K; Kinoshita T; Nakamura S
Pathol Int; 2014 Jul; 64(7):336-45. PubMed ID: 25047504
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Study of 30 Cases of Peripheral T-cell Lymphoma with Hodgkin and Reed-Sternberg-like B-cells from Japan.
Eladl AE; Satou A; Elsayed AA; Suzuki Y; Kato S; Asano N; Nakamura S
Am J Surg Pathol; 2017 Apr; 41(4):506-516. PubMed ID: 28125450
[TBL] [Abstract][Full Text] [Related]
13. [Expression and clinical significance of nm23-H1 and MUC-1 in peripheral T-cell lymphoma].
Huang HQ; Pan ZH; Lin XB; Wang BF; Hou JH; Zhang Y; Wu QL
Ai Zheng; 2006 Dec; 25(12):1517-23. PubMed ID: 17166378
[TBL] [Abstract][Full Text] [Related]
14. Hemoglobin-platelet index as a prognostic factor in patients with peripheral T-cell lymphoma.
Yagi Y; Kanemasa Y; Sasaki Y; Okumura S; Watanabe T; Ishimine K; Hayashi Y; Mino M; Ohigashi A; Morita Y; Tamura T; Nakamura S; Okuya T; Shimoyama T
EJHaem; 2023 Aug; 4(3):656-666. PubMed ID: 37601871
[TBL] [Abstract][Full Text] [Related]
15. FoxP3-positive T cell lymphoma arising in non-HTLV1 carrier: clinicopathological analysis of 11 cases of PTCL-NOS and 2 cases of mycosis fungoides.
Satou A; Asano N; Kato S; Katsuya H; Ishitsuka K; Elsayed AA; Nakamura S
Histopathology; 2016 Jun; 68(7):1099-108. PubMed ID: 26426838
[TBL] [Abstract][Full Text] [Related]
16. High viral loads of circulating Epstein-Barr virus DNA copy number in peripheral blood is associated with inferior prognosis in patients with mantle cell lymphoma.
Zhou XH; Liang JH; Wang L; Zhu HY; Wu JZ; Xia Y; Li Y; Qin SC; Fan L; Li JY; Xu W
J Cancer; 2020; 11(17):4980-4988. PubMed ID: 32742445
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus (EBV) DNA in whole blood as a superior prognostic and monitoring factor than EBV-encoded small RNA in situ hybridization in diffuse large B-cell lymphoma.
Liang JH; Lu TX; Tian T; Wang L; Fan L; Xu J; Zhang R; Gong QX; Zhang ZH; Li JY; Xu W
Clin Microbiol Infect; 2015 Jun; 21(6):596-602. PubMed ID: 25743579
[TBL] [Abstract][Full Text] [Related]
18. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.
Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T
Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138
[TBL] [Abstract][Full Text] [Related]
19. Peripheral T-cell lymphoma with progression to a clonally related, Epstein Barr virus+, cytotoxic aggressive T-cell lymphoma: evidence for secondary EBV infection of an established malignant T-cell clone.
Langer R; Geissinger E; Rüdiger T; von Schilling C; Ott G; Mandl-Weber S; Quintanilla-Martinez L; Fend F
Am J Surg Pathol; 2010 Sep; 34(9):1382-7. PubMed ID: 20739840
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features.
Balagué O; Martínez A; Colomo L; Roselló E; Garcia A; Martínez-Bernal M; Palacín A; Fu K; Weisenburger D; Colomer D; Burke JS; Warnke RA; Campo E
Am J Surg Pathol; 2007 Sep; 31(9):1310-22. PubMed ID: 17721185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
